Editorial

Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. The Journal publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.

Publishing Staff

Ron Waksman, M.D.

Frequency

4 issues/year

For supplement sponsor information.

Back to Top

Product Advertising Sales Christy Tetterton International Medical News Group 60 Columbia Rd. Bldg. B Morristown, NJ 07960 Tel: 973-290-8231 Fax: 973-290-8250/8245 c.tetterton@elsevier.com
Reprints Anna Rosenthal Elsevier 360 Park Avenue South New York, NY 10010 Tel: 212-633-3812 Fax: 212-633-3820 reprints@elsevier.com	Supplements Christy Tetterton International Medical News Group 60 Columbia Rd. Bldg. B Morristown, NJ 07960 Tel: 973-290-8231 Fax: 973-290-8250/8245 c.tetterton@elsevier.com